+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Morphine Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129743
Global Morphine Market Size, Share & Trends Analysis Report, by Type (Capsules, Oral Tablets, and Injection), by Application (Cough Suppressant, Diarrhea Suppressant, and Anesthesia) and Forecast Period, 2020-2026
The global morphine market is estimated to grow significantly during the forecast period. The major factors encouraging market growth include the rising demand for extended-release morphine drugs for long term pain management. Moreover, change in lifestyle and increases the demand during surgical procedures is also contributing to the market growth. There are various drugs available in the market. One of the novel products is Dsuvia, one of the morphine drugs used by medical professionals under restricted regulations that are prescribed for emergency cases, in surgical operations by hospitals. Dsuvia dosage only prescribed when the patient is incapable to swallow the medicine.

The global morphine market is segmented based on type and application. Based on type, the market is classified into capsules, oral tablets and injection. Based on the application, the market is classified into cough suppressants, diarrhea suppressants, anesthesia, and others. Geographically, the global Morphine market is classified into North America, Europe, Asia-Pacific and Rest of world. North America dominates the global morphine market due to high consumption of morphine in research & development for medical innovation.

The major companies providing morphine include Allergan PLC, Purdue Pharma LP, Mallinckrodt PLC, Mylan N.V., Sun Pharmaceutical Industries, Ltd., Macfarian Smith, Ltd., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries, Ltd. Are among others. These players are adopting various strategies in order to stay competitive in the market. For instance, in July 2018, Sun Pharmaceuticals Industries Ltd. Introduced Morphine sulfate extended to reduce the severe pain for long-term opioid treatments.

Research Methodology

The market study of the global morphine market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity tthe reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global Morphine Market Research and Analysis by Type
  • Global Morphine Market Research and Analysis by Application

The Report covers:
  • Comprehensive research methodologies of the global morphine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global morphine market.
  • Insights about market determinants which are stimulating the global morphine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Allergan PLC Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Purdue Pharma LP Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Mallinckrodt PLC Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Mylan N.V. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Sun Pharmaceutical Industries, Ltd. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Morphine Market by Type
5.1.1. Injection
5.1.2. Capsule
5.1.3. Oral Tablets
5.2. Global Morphine Market by Application
5.2.1. Cough Suppressant
5.2.2. Diarrhea Suppressant
5.2.3. Anesthesia
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Allergan PLC
7.2. Alcaliber S.A.
7.3. Daiichi Sankyo, Inc.
7.4. Macfarian Smith, Ltd. (A Part of Johnson Matthey PLC’s Fine Chemicals Division)
7.5. Mallinckrodt PLC
7.6. Manus Aktteva Biopharma LLP
7.7. Mylan N.V.
7.8. Mayne Pharma Group, Ltd.
7.9. Pfizer, Inc.
7.10. Purdue Pharma LP
7.11. Sanofi S.A.
7.12. Sun Pharmaceuticals Industries, Ltd.
7.13. Taj Pharmaceuticals, Ltd.
7.14. Takeda Pharmaceutical Co. Ltd.
7.15. Teva Pharmaceutical Industries, Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan PLC
  • Alcaliber S.A.
  • Daiichi Sankyo, Inc.
  • Macfarian Smith, Ltd. (A Part of Johnson Matthey PLC’s Fine Chemicals Division)
  • Mallinckrodt PLC
  • Manus Aktteva Biopharma LLP
  • Mylan N.V.
  • Mayne Pharma Group, Ltd.
  • Pfizer, Inc.
  • Purdue Pharma LP
  • Sanofi S.A.
  • Sun Pharmaceuticals Industries, Ltd.
  • Taj Pharmaceuticals, Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries, Ltd.